Mackenzie Financial Corp Increases Holdings in CME Group Inc. $CME

Mackenzie Financial Corp increased its position in CME Group Inc. (NASDAQ:CMEFree Report) by 18.0% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 1,379,851 shares of the financial services provider’s stock after acquiring an additional 210,642 shares during the period. Mackenzie Financial Corp owned approximately 0.38% of CME Group worth $380,315,000 as of its most recent SEC filing.

A number of other institutional investors also recently bought and sold shares of CME. Webster Bank N. A. raised its stake in shares of CME Group by 206.9% during the 2nd quarter. Webster Bank N. A. now owns 89 shares of the financial services provider’s stock worth $25,000 after buying an additional 60 shares during the last quarter. Highline Wealth Partners LLC increased its holdings in CME Group by 84.3% during the 2nd quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 43 shares in the last quarter. Ransom Advisory Ltd acquired a new position in CME Group during the first quarter worth about $31,000. Trifecta Capital Advisors LLC grew its position in shares of CME Group by 59.2% in the second quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 42 shares during the last quarter. Finally, Westside Investment Management Inc. increased its stake in shares of CME Group by 105.0% during the 2nd quarter. Westside Investment Management Inc. now owns 123 shares of the financial services provider’s stock worth $34,000 after purchasing an additional 63 shares in the last quarter. 87.75% of the stock is currently owned by hedge funds and other institutional investors.

Insider Transactions at CME Group

In other news, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction dated Tuesday, September 16th. The stock was sold at an average price of $259.83, for a total transaction of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares in the company, valued at approximately $2,470,463.64. The trade was a 3.83% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, General Counsel Jonathan L. Marcus sold 392 shares of the firm’s stock in a transaction that occurred on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the completion of the transaction, the general counsel owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 2,147 shares of company stock worth $562,079 in the last three months. 0.30% of the stock is currently owned by insiders.

CME Group Trading Up 0.2%

Shares of CME stock opened at $281.50 on Friday. The firm’s 50-day simple moving average is $270.60 and its 200-day simple moving average is $272.71. The company has a debt-to-equity ratio of 0.12, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 1-year low of $224.62 and a 1-year high of $290.79. The firm has a market cap of $101.51 billion, a P/E ratio of 27.28, a PEG ratio of 4.41 and a beta of 0.38.

CME Group (NASDAQ:CMEGet Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, topping the consensus estimate of $2.63 by $0.05. The firm had revenue of $1.54 billion during the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. CME Group’s revenue for the quarter was down 3.0% compared to the same quarter last year. During the same quarter in the prior year, the business posted $2.68 earnings per share. As a group, equities analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 30th. Investors of record on Friday, December 12th will be issued a $1.25 dividend. The ex-dividend date is Friday, December 12th. This represents a $5.00 dividend on an annualized basis and a yield of 1.8%. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analysts Set New Price Targets

Several equities analysts have weighed in on CME shares. Weiss Ratings reissued a “buy (b)” rating on shares of CME Group in a research report on Wednesday, October 8th. TD Cowen lifted their price objective on CME Group from $288.00 to $290.00 and gave the stock a “hold” rating in a research report on Thursday, October 23rd. Keefe, Bruyette & Woods upped their target price on shares of CME Group from $283.00 to $287.00 and gave the company a “market perform” rating in a report on Monday, October 13th. UBS Group lowered their price target on shares of CME Group from $285.00 to $280.00 and set a “neutral” rating for the company in a report on Thursday, October 23rd. Finally, Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Eight analysts have rated the stock with a Buy rating, seven have given a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus price target of $287.71.

Get Our Latest Analysis on CME

CME Group Company Profile

(Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Recommended Stories

Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CMEFree Report).

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.